TNTristan Naidoo

Tristan Naidoo

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Tristan Naidoo has a total of 127 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • A systematic review of Nipah virus disease epidemiological parameters, outbreaks, and mathematical models

    by Tristan Naidoo, Christian Morgenstern, Patrick Doohan, Rhys Earl, Thomas Rawson, Richard J Sheppard, Joseph T Hicks, Sreejith Radhakrishnan, Rob Johnson, Anna-Maria Hartner, et al.


  • Open Access

    Federated analysis of incubation period distributions using individual-level observed data and heterogeneous summary statistics

    by Christian Morgenstern, Mark P. Khurana, Tristan Naidoo, Thomas Rawson, Anne Cori, David A Duchene, Neil M Ferguson, Moritz U. G. Kraemer, Samir Bhatt

    The incubation period, the interval between pathogen exposure and symptom onset, is a critical epidemiological parameter for follow-up policy and outbreak response, yet individual-level exposure data remain scarce, especially early in outbreaks. For most priority pathogens, only summary statistics are available because sharing of individual-level data can be sensitive. Here we introduce a Bayesian hierarchical framework that jointly models individual-level observations and published summary statistics under a unified federated analysis framework. Simulation studies demonstrate that the method accurately recovers incubation period distributions across a range of data availability scenarios, generally outperforming approaches that use published summary statistics alone. Applying the framework to 18 pathogens, including 10 priority pathogens classified to have outbreak potential by the World Health Organization, we find substantial between-study heterogeneity in incubation period estimates, including by outbreak country for SARS-CoV-1, variants of concern for COVID-19, and exposure setting for typhoid fever. These estimates, together with the curated dataset and modelling framework in our associated R package ddsynth , provide a reproducible foundation for improved incubation period estimation and synthesis across pathogens of epidemic concern. Our framework enables robust and rapid estimation of incubation periods during new outbreaks.

  • Open Access

    A systematic review of Nipah virus disease epidemiological parameters, outbreaks and mathematical models

    by Tristan M Naidoo, Christian Morgenstern, Patrick Doohan, Rhys Earl, Thomas Rawson, Richard J Sheppard, Joseph T Hicks, Sreejith Radhakrishnan, Rob Johnson, Anna-Maria Hartner, et al.

    We conducted a systematic review (PROSPERO CRD42023393345) characterising the epidemiology, outbreaks and mathematical models of Nipah virus (NiV), an important public health threat in South and Southeast Asia. We extracted 243 parameters, 89 risk factors, 39 models and 23 distinct outbreaks from 119 papers. IgG seroprevalence estimates ranged from 0% to 12.5%. NiV causes severe disease, with pooled case-fatality ratio estimates ranging widely from 9.1% (95%CI: 0.2%-41.3%) in Singapore to 81.9% (95%CI: 71.9%-88.9%) in Bangladesh. NiV’s natural history is poorly characterised; we estimated a median incubation period of 8.77 days (95%CI: 7.53-10.02) based on 8 studies. Transmission parameter estimates were scarce, and all but one central estimate of the basic reproduction number were below 1. NiV mathematical models (n=39) were rarely fitted to data (n=8). All extracted information is accessible via our R package, epireview , a dynamic resource for informing responses to future outbreaks of NiV and related pathogens.


  • Open Access

    Examining gender and ethnic disparities in scientific authorship to promote a culture of equity, diversity and inclusion at a university school of public health

    by Paula Christen, Julia Michalow, Tristan Naidoo, Hillary Topazian, Sabine L. van Elsland, Abeer M. Arif, Marc Baguelin, Gemma Clunie, Sarah Essilfie-Quaye, Daniela Fecht, et al.

    In public health research, diverse perspectives are vital to identify biases that homogenous teams might miss. Since publication metrics influence career progression, we investigated publication rate disparities within a School of Public Health. We analysed 18 322 peer-reviewed publications by 513 affiliated researchers between 2014 and 2023 using multivariable regression models and network analysis to assess the impact of gender, ethnicity, job level and centrality in the School’s research network on publication rates. We found a persistent gender gap in publication rates across job levels and ethnicities, with men publishing more than women (incidence rate ratio 1.30, 95% confidence interval (CI): 1.15–1.46). This disparity was present from early career levels and amplified in senior roles, where men were over-represented (71.2% of men at Professor level). Unadjusted analyses indicated higher publication rates for white researchers (median of one publication more per person per year). The COVID-19 pandemic led to increased publication rates for both genders, but the gender gap persisted, with men publishing 1.27 (95% CI: 1.10–1.46) times more than women in 2020/2021. This study underscores the need to identify and address root causes of these disparities to foster an inclusive research environment where diverse contributions are recognized and valued.


  • Open Access

    A systematic review of Zika virus disease: epidemiological parameters, mathematical models, and outbreaks

    by Kelly McCain, Anna Vicco, Christian Morgenstern, Thomas Rawson, Tristan M. Naidoo, Sangeeta Bhatia, Dominic P. Dee, Patrick Doohan, Keith Fraser, Anna-Maria Hartner, et al.

    Background: Zika virus (ZIKV) is an Aedes-borne arbovirus that can cause serious risks of neurological complications and birth defects in newborns of mothers infected during pregnancy. ZIKV is classified as a priority pathogen by the World Health Organization. Methods: We conducted a systematic review of peer-reviewed studies reporting ZIKV epidemiological parameters, transmission models, and outbreaks (PROSPERO #CRD42023393345) to characterise its transmissibility, seroprevalence, risk factors, disease sequelae, and natural history. We performed a meta-analysis of Congenital Zika Syndrome (CZS), pregnancy loss probabilities amongst ZIKV-infected mothers and the proportion of symptomatic cases. Findings: We extracted information from 574 of 27,491 identified studies. Across 418 included studies assigned a high-quality score, we extracted 969 parameters, 127 outbreak records, and 154 models. We estimated a pooled total random effect of CZS probability (4.65%), pregnancy loss probability (2.48%), and proportion of symptomatic cases (51.20%). Seroprevalence estimates (n=354) were retrieved beyond South America and French Polynesia. The basic reproduction number estimates (n=77) ranged between 1.12 and 7.4. We found 66 human epidemiological delay estimates, ranging 4-12.1 days for the intrinsic incubation period (n=11), 3-50 days for the infectious period (n=15), 5.1-24.2 days for the extrinsic incubation period (n=22), and 7.4-32.9 days for the serial interval (n=27). These data are available in the R package epireview . Interpretation: This study provides the most comprehensive systematic summary of the ZIKV epidemiological information currently available in the literature. Large heterogeneities and inconsistencies in the reporting of parameter estimates, study designs, and parameter definitions were found, underscoring the need for standardised epidemiological definitions in future publications. Funding: Academy of Medical Sciences, British Heart Foundation, Community Jameel, Diabetes UK, Imperial College London, National Institute for Health and Care Research, Royal Society, Schmidt Sciences, UK Department for Business, Energy, and Industrial Strategy, UK Medical Research Council, United Nations Foundation, Wellcome Trust. Research in Context: Evidence before this study: We searched Web of Science and PubMed from database inception to October 31, 2024 to collate epidemiological parameters, mathematical models, and outbreaks of Zika virus (ZIKV). We found 66 systematic reviews on ZIKV since 2016: of these, 29 focussed on Congenital Zika Syndrome (CZS) and/or Guillain-Barré Syndrome, 19 on ZIKV transmission, 16 on the distribution and burden of ZIKV infection and disease and the remaining on clinical presentation, severity, forecasting, time-to-event, risk mapping and vaccines and therapeutics. The published systematic reviews included between 4 to 204 publications, and most (75%) had a global scope. Only 5 systematic reviews conducted a meta-analysis assessing the overall probability of CZS upon infection in the mother, and only 1 review investigated the probability of CZS by trimester of pregnancy (using 2 articles). Added value of this study: In this systematic review, we extracted information from 574 relevant studies, which makes this the most comprehensive synthesis of Zika parameters for outbreak response to date. From 418 studies with a high-quality assessment score, we extracted 969 epidemiological parameters, 127 outbreak records and 154 transmission models, most of which were published after the 2016 outbreak. We extracted and analysed 354 geolocated and time-stamped seroprevalence estimates; 100 basic and 15 effective reproduction number estimates from 21 countries; 66 human epidemiological delays and 22 extrinsic incubation periods. Our meta-analysis provides robust pooled estimates of the proportion of symptomatic cases (51.20%) and CZS probability (4.65%), also stratified by trimester based on maternal ZIKV infection (based on 7 publications), addressing a gap present in most previous reviews. Implications of all the available evidence: This study provides the most comprehensive overview of ZIKV epidemiology to date, serving as a valuable resource for future modelling studies and stakeholders developing preparedness and response plans to control future outbreaks.

  • Open Access

    Examining gender and ethnic disparities in scientific authorship to promote a culture of equity, diversity and inclusion at a university school of public health

    by Paula Christen, Julia Michalow, Tristan Naidoo, Hillary Topazian, Sabine van Elsland, Abeer M Arif, Marc Baguelin, Gemma Clunie, Daniela Fecht, Tini Garske, et al.

    While fostering equity, diversity, and inclusion in the workplace is crucial for many reasons, in public health research, diverse perspectives are particularly vital to identify biases that homogenous teams might miss. Given that publication metrics often influence career progression, we investigated gender and ethnic disparities in publication rates within Imperial College London’s School of Public Health. We analysed 18,322 peer-reviewed publications by 513 affiliated researchers between 2014 and 2023. We used mixed-effects multivariable regression models to assess the impact of gender, ethnicity, and job level on publication rates. Network analysis of co-authorships was performed to evaluate each author’s centrality in the department’s research network. We found a persistent gender gap in publication rates across all job levels and ethnicities, with men publishing more than women (incidence rate ratio (IRR) 1.30 95% Confidence Interval (CI): 1.15 – 1.46). This disparity was present from early career levels and amplified in senior roles, where men were overrepresented (71.2% of men at Professor level). Internal collaboration rates were similar between genders. Unadjusted analyses indicated higher publication rates for white researchers (median of 1 publication more per person per year), although there were limitations in the ethnicity classification algorithm. The COVID-19 pandemic led to increased publication rates for both genders, but the gender gap persisted, with men publishing 1.27 (95% CI: 1.10 – 1.46) times more than women in 2020 - 2021. A complex interplay of factors may contribute to publication disparities, including differences in research contributions, systemic barriers, and potential biases in research allocation, mentorship, and promotion processes. This study underscores the need to identify and address the root causes of these disparities to foster an inclusive research environment where diverse contributions are recognized and valued.


  • Open Access

    Severe acute respiratory syndrome (SARS) mathematical models and disease parameters: a systematic review and meta-analysis

    by Christian Morgenstern, Thomas Rawson, Isobel Routledge, Mara Kont, Natsuko Imai-Eaton, Janetta Skarp, Patrick Doohan, Kelly McCain, Rob Johnson, H. Juliette T. Unwin, et al.

    We conducted a systematic review (PROSPERO CRD42023393345) of severe acute respiratory syndrome (SARS) transmission models and parameters characterising its transmission, evolution, natural history, severity, risk factors and seroprevalence. Information was extracted using a custom database and quality assessment tool. We extracted 519 parameters, 243 risk factors, and 112 models from 288 papers. Our analyses show SARS is characterised by high lethality (case fatality ratio 10.9%), transmissibility (R 0 range 1.1-4.59), and is prone to superspreading (20% top infectors causing up to 91% of infections). Infection risk was highest among healthcare workers and close contacts of infected individuals. Severe disease and death were associated with age and existing comorbidities. SARS’s natural history is poorly characterised, except for the incubation period and mean onset-to-hospitalisation. Our associated R package, epireview, contains this database, which can continue to be updated to maintain a living review of SARS epidemiology and models, thus providing a key resource for informing response to future coronavirus outbreaks.


  • Open Access

    Lassa fever outbreaks, mathematical models, and disease parameters: a systematic review and meta-analysis

    by Patrick Doohan, David Jorgensen, Tristan M. Naidoo, Kelly McCain, Joseph T. Hicks, Ruth McCabe, Sangeeta Bhatia, Kelly Charniga, Gina Cuomo-Dannenburg, Arran Hamlet, et al.

    Background: Lassa fever, caused by Lassa virus (LASV), poses a significant public health threat in West Africa. Understanding the epidemiological parameters and transmission dynamics of LASV is crucial for informing evidence-based interventions and outbreak response strategies. Methods: We conducted a systematic review (PROSPERO CRD42023393345) to compile and analyse key epidemiological parameters, mathematical models, and past outbreaks of LASV. Data were double extracted from published literature, focusing on past outbreaks, seroprevalence, transmissibility, epidemiological delays, and disease severity. Findings: We found 157 publications meeting our inclusion criteria and extracted 374 relevant parameter estimates. Although LASV is endemic in West Africa, spatiotemporal coverage of recent seroprevalence estimates, ranging from 0.06% to 35%, was poor. Highlighting the uncertainty in LASV risk spatially. Similarly, only two basic reproduction number estimates at 1.13 and 1.19 were available. We estimated a pooled total random effect case fatality ratio of 33.1% (95% CI: 25.7 – 41.5, I 2 = 94%) and found potential variation in severity by geographic regions typically associated with specific LASV lineages. We estimated a pooled total random effect mean symptom-onset-to-hospital-admission delay of 8.3 days (95% CI: 7.4 – 9.3, I2 = 92%), but other epidemiological delays were poorly characterised. Interpretation: Our findings highlight the relative lack of empirical LASV parameter estimates despite its high severity. Improved surveillance to capture mild cases and approaches that integrate rodent populations are needed to better understand LASV transmission dynamics. Addressing these gaps is essential for developing accurate mathematical models and informing evidence-based interventions to mitigate the impact of Lassa fever on public health in endemic regions. Funding: UK Medical Research Council, National Institute for Health and Care Research, Academy of Medical Sciences, Wellcome, UK Department for Business, Energy, and Industrial Strategy, British Heart Foundation, Diabetes UK, Schmidt Foundation, Community Jameel, Royal Society, and Imperial College London. Research in Context: Evidence before this study: We searched PubMed up to August 2, 2023 for ((lassa fever) or (lassa virus)) and (epidemiology or outbreak or (models not image) or transmissibility or severity or delays or (risk factors) or (mutation rate) or seroprevalence). We found ten systematic reviews. Three on ribavirin as a Lassa fever treatment, two on Lassa virus (LASV) vaccine candidates, and one each on historical importations of Lassa fever cases from West Africa to non-endemic countries, clinical characteristics for protocol development, and Lassa fever in pregnancy. Two systematically reviewed epidemiological parameters. One on basic reproduction number estimates which ranged from 1.1 to 1.8 for human-to-human and 1.5 to 1.7 for rodent-to-rodent transmission. However, no meta-analyses were conducted. The other focused on LASV infection case fatality ratios (CFRs): 29.7% (22.3–37.5) in humans and prevalence: 8.7% (95% confidence interval: 6.8– 10.8) in humans, 3.2% (1.9–4.6) in rodents, and 0.7% (0.0–2.3) in other mammals. There were no systematic reviews on LASV transmission models. Added value of this study: We provide a comprehensive overview of published outbreaks, transmission models and epidemiological parameters for LASV. We highlight the sparsity of key epidemiological parameter estimates such as the serial interval or generation time. The discrepancy between the high overall severity and the high seroprevalence in the general population suggests a high proportion of infections are asymptomatic or only result in mild disease. Therefore, current surveillance systems may need refining to better characterise LASV transmission dynamics. Implications of all the available evidence: Epidemiological models are useful tools for real-time analysis of outbreaks, assessing epidemic trajectories and the impact of interventions. Our study is a useful basis to inform future LASV models, but highlights uncertainties and knowledge gaps that need to be filled in LASV transmission and natural history. Future LASV studies will benefit from integrating human and rodent reservoir surveillance.


  • Open Access

    A descriptive study of the relationship between preoperative body temperature and intraoperative core temperature change in adults under general anaesthesia

    by F Steyn, L Du Toit, T Naidoo, R Hofmeyr

    Despite numerous guidelines on perioperative temperature management, perioperative hypothermia remains common. Prewarming to prevent redistribution hypothermia is supported by evidence, but not widely practised. We investigate the measurement of preoperative mean body temperature as a potential tool for individualising the practice of prewarming. We hypothesised that patients who experience intraoperative hypothermia have a lower preoperative mean body temperature. A longitudinal study was conducted in adult patients presenting for ophthalmological surgery under general anaesthesia, to describe the relationship between the incidence of hypothermia within the first hour of anaesthesia and preoperative mean body temperature. Sixty-five patients were enrolled. Twelve participants (18%) presented to the operating theatre hypothermic (core temperature < 36.0 °C). A further 28 (43%) became hypothermic during the procedure. All hypothermia events occurred within 60 minutes after induction of anaesthesia, and half of the events occurred within 19 minutes. The difference in preoperative mean body temperature between those with and without intraoperative hypothermia was only -0.2 °C (95% CI -0.4, 0.1). This is neither clinically relevant nor statistically noteworthy. In Cox proportional hazards analysis, BMI and ASA status compounded the observed association between preoperative mean body temperature and the incidence of intraoperative hypothermia. A higher BMI and ASA are associated with a lower incidence of hypothermia. We conclude that intraoperative hypothermia is common and occurs early after induction of anaesthesia. We observed no useful difference in preoperative mean body temperature to help distinguish between patients who become hypothermic and those who do not. Without a useful risk prediction tool, a generic approach to prewarming remains appropriate. Preoperative screening for pre-existing hypothermia should be practised, even in cases considered as low risk.